# JAGSNPHARM — Jagsonpal Pharmaceuticals Limited

> Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) on the NSE: 7,087 sessions of split-adjusted history from 1996.

Canonical: https://patternsradar.com/s/JAGSNPHARM

## Latest session

- Close: 236.54 INR (1.52% on the day), 2026-08-21
- Delivery: 53.95% of volume taken to demat (20-day average 45.52%)
- Volume: 92.8K shares, turnover ₹2.2Cr
- Relative volume: 0.11× of its own 20-day average

## Technicals

- RSI(14): 56.96
- ATR(14): 8.79
- SMA 50: 227.97, SMA 200: 201.87
- 52-week range: 155 – 264.5 (-10.57% from the high)

## Performance

- 1 week 4.41%, 1 month 8.59%, 3 months 12.68%
- 6 months 36.34%, 1 year -5.78%

## Fundamentals

- Market cap: 1,559.5 crore
- P/E (TTM): 34.29 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 6.9 INR, split-adjusted to match the price series
- Revenue growth: 8.76% YoY, 28.08% QoQ
- Profit growth: 22.18% YoY, 50.52% QoQ

## Quarterly results

Last 8 filed quarters, standalone basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 74.7 | 61 | 15.4 | 11.5 | 1.72 | 15.34% |
| 2024-12-31 | 74 | 60.9 | 38.7 | 32 | 1.9 | 43.22% |
| 2025-03-31 | 58.6 | 52.4 | 8.7 | 6.6 | 0.98 | 11.24% |
| 2025-06-30 | 75.6 | 64 | 14.4 | 10.8 | 1.6 | 14.28% |
| 2025-09-30 | 74.5 | 60.7 | 16.8 | 12.6 | 1.88 | 16.89% |
| 2025-12-31 | 72.9 | 59.3 | 14.5 | 11 | 1.67 | 15.01% |
| 2026-03-31 | 64.2 | 55.6 | 11.8 | 8.8 | 1.25 | 13.65% |
| 2026-06-30 | 82.2 | 67.4 | 17.7 | 13.2 | 2 | 16.04% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 69.05%
- Public: 30.95%

Institutional and pledge percentages come from a filing stage whose backfill has reached about 1% of instruments, so they are absent here rather than zero.

## Recent filings

- 2026-07-29: results for 2026-06-30 standalone — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_180100_29072026192314_iXBRL_WEB.html
- 2026-07-13: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1691431_13072026040836_WEB.xml
- 2026-06-09: shareholding for 2026-06-02 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1680438_09062026032322_WEB.xml
- 2026-05-04: buyback
- 2026-04-27: results for 2026-03-31 standalone — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_153335_27042026205818_iXBRL_WEB.html
- 2026-04-21: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1656361_21042026045546_WEB.xml
- 2026-01-21: results for 2025-12-31 standalone — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_136445_21012026173707_iXBRL_WEB.html
- 2026-01-15: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1601619_15012026045037_WEB.xml

Dated by the day the company broadcast the filing. 112 events are indexed for this instrument.

## About the instrument

- Listed: 1996-09-13 — latest session 2026-08-21 (7,087 sessions)
- ISIN: INE048B01035
- Series: EQ
- Liquidity rank: #791 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/JAGSNPHARM.